Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

A cluster of continuous antigenic structures in the transmembrane protein of HIV-1: individual patterns of reactivity in human sera.

Identifieur interne : 002995 ( PubMed/Curation ); précédent : 002994; suivant : 002996

A cluster of continuous antigenic structures in the transmembrane protein of HIV-1: individual patterns of reactivity in human sera.

Auteurs : P J Klasse [Suède] ; R. Pipkorn ; J. Blomberg

Source :

RBID : pubmed:1713646

Descripteurs français

English descriptors

Abstract

We investigated the antigenicity of a highly conserved region in the transmembrane protein of the human immunodeficiency virus type 1 (HIV-1). In order to identify antigenically important residues, amino-acid sequences of synthetic peptides representing this region were varied systematically: single residues were omitted from the sequence of HIV-env 583-599; threonines were substituted for pairs of residues in HIV-env 581-599; the sequences of heptadeca-peptides were shifted by single residues. The peptides were tested in an enzyme immuno-assay against fourteen HIV-1 antibody-positive human sera, which were previously found to react with HIV-env 583-599, and against rabbit antisera to the peptides HIV-env 583-599 and 586-606. Substitutions as well as deletions in the sequence 589-596 (AVERYLKD) aborgated the antigenicity of the peptides with most of the human sera. Changes outside this sequence affected the reactivities differentially. Six overlapping dodeca-peptides, shifted in the sequence by single residues, lacked antigenicity in a competition assay, suggesting antigenic dependence on an ordered peptide conformation, which the longer peptides may preferentially assume. 19- and 21-mers with overlapping sequences competed to different extents with each other for binding to the antibodies of 3 human sera, illustrating that more than one antigenic structure in this narrow region can be recognized by a single polyclonal serum.

DOI: 10.1016/0161-5890(91)90130-c
PubMed: 1713646

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:1713646

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">A cluster of continuous antigenic structures in the transmembrane protein of HIV-1: individual patterns of reactivity in human sera.</title>
<author>
<name sortKey="Klasse, P J" sort="Klasse, P J" uniqKey="Klasse P" first="P J" last="Klasse">P J Klasse</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medical Microbiology, University of Lund, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Department of Medical Microbiology, University of Lund</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Pipkorn, R" sort="Pipkorn, R" uniqKey="Pipkorn R" first="R" last="Pipkorn">R. Pipkorn</name>
</author>
<author>
<name sortKey="Blomberg, J" sort="Blomberg, J" uniqKey="Blomberg J" first="J" last="Blomberg">J. Blomberg</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="1991">1991</date>
<idno type="RBID">pubmed:1713646</idno>
<idno type="pmid">1713646</idno>
<idno type="doi">10.1016/0161-5890(91)90130-c</idno>
<idno type="wicri:Area/PubMed/Corpus">002995</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002995</idno>
<idno type="wicri:Area/PubMed/Curation">002995</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002995</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">A cluster of continuous antigenic structures in the transmembrane protein of HIV-1: individual patterns of reactivity in human sera.</title>
<author>
<name sortKey="Klasse, P J" sort="Klasse, P J" uniqKey="Klasse P" first="P J" last="Klasse">P J Klasse</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Medical Microbiology, University of Lund, Sweden.</nlm:affiliation>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Department of Medical Microbiology, University of Lund</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Pipkorn, R" sort="Pipkorn, R" uniqKey="Pipkorn R" first="R" last="Pipkorn">R. Pipkorn</name>
</author>
<author>
<name sortKey="Blomberg, J" sort="Blomberg, J" uniqKey="Blomberg J" first="J" last="Blomberg">J. Blomberg</name>
</author>
</analytic>
<series>
<title level="j">Molecular immunology</title>
<idno type="ISSN">0161-5890</idno>
<imprint>
<date when="1991" type="published">1991</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Amino Acid Sequence</term>
<term>Binding Sites, Antibody</term>
<term>Epitopes</term>
<term>HIV Envelope Protein gp41 (immunology)</term>
<term>HIV-1 (immunology)</term>
<term>Humans</term>
<term>Immunoenzyme Techniques</term>
<term>In Vitro Techniques</term>
<term>Molecular Conformation</term>
<term>Molecular Sequence Data</term>
<term>Threonine (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Conformation moléculaire</term>
<term>Données de séquences moléculaires</term>
<term>Humains</term>
<term>Protéine d'enveloppe gp41 du VIH (immunologie)</term>
<term>Sites de fixation des anticorps</term>
<term>Séquence d'acides aminés</term>
<term>Techniques immunoenzymatiques</term>
<term>Techniques in vitro</term>
<term>Thréonine (immunologie)</term>
<term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1) (immunologie)</term>
<term>Épitopes</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en">
<term>HIV Envelope Protein gp41</term>
<term>Threonine</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>Epitopes</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Protéine d'enveloppe gp41 du VIH</term>
<term>Thréonine</term>
<term>VIH-1 (Virus de l'Immunodéficience Humaine de type 1)</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>HIV-1</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Amino Acid Sequence</term>
<term>Binding Sites, Antibody</term>
<term>Humans</term>
<term>Immunoenzyme Techniques</term>
<term>In Vitro Techniques</term>
<term>Molecular Conformation</term>
<term>Molecular Sequence Data</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Conformation moléculaire</term>
<term>Données de séquences moléculaires</term>
<term>Humains</term>
<term>Sites de fixation des anticorps</term>
<term>Séquence d'acides aminés</term>
<term>Techniques immunoenzymatiques</term>
<term>Techniques in vitro</term>
<term>Épitopes</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">We investigated the antigenicity of a highly conserved region in the transmembrane protein of the human immunodeficiency virus type 1 (HIV-1). In order to identify antigenically important residues, amino-acid sequences of synthetic peptides representing this region were varied systematically: single residues were omitted from the sequence of HIV-env 583-599; threonines were substituted for pairs of residues in HIV-env 581-599; the sequences of heptadeca-peptides were shifted by single residues. The peptides were tested in an enzyme immuno-assay against fourteen HIV-1 antibody-positive human sera, which were previously found to react with HIV-env 583-599, and against rabbit antisera to the peptides HIV-env 583-599 and 586-606. Substitutions as well as deletions in the sequence 589-596 (AVERYLKD) aborgated the antigenicity of the peptides with most of the human sera. Changes outside this sequence affected the reactivities differentially. Six overlapping dodeca-peptides, shifted in the sequence by single residues, lacked antigenicity in a competition assay, suggesting antigenic dependence on an ordered peptide conformation, which the longer peptides may preferentially assume. 19- and 21-mers with overlapping sequences competed to different extents with each other for binding to the antibodies of 3 human sera, illustrating that more than one antigenic structure in this narrow region can be recognized by a single polyclonal serum.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">1713646</PMID>
<DateCompleted>
<Year>1991</Year>
<Month>09</Month>
<Day>03</Day>
</DateCompleted>
<DateRevised>
<Year>2019</Year>
<Month>08</Month>
<Day>24</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0161-5890</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>28</Volume>
<Issue>6</Issue>
<PubDate>
<Year>1991</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>Molecular immunology</Title>
<ISOAbbreviation>Mol. Immunol.</ISOAbbreviation>
</Journal>
<ArticleTitle>A cluster of continuous antigenic structures in the transmembrane protein of HIV-1: individual patterns of reactivity in human sera.</ArticleTitle>
<Pagination>
<MedlinePgn>613-22</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>We investigated the antigenicity of a highly conserved region in the transmembrane protein of the human immunodeficiency virus type 1 (HIV-1). In order to identify antigenically important residues, amino-acid sequences of synthetic peptides representing this region were varied systematically: single residues were omitted from the sequence of HIV-env 583-599; threonines were substituted for pairs of residues in HIV-env 581-599; the sequences of heptadeca-peptides were shifted by single residues. The peptides were tested in an enzyme immuno-assay against fourteen HIV-1 antibody-positive human sera, which were previously found to react with HIV-env 583-599, and against rabbit antisera to the peptides HIV-env 583-599 and 586-606. Substitutions as well as deletions in the sequence 589-596 (AVERYLKD) aborgated the antigenicity of the peptides with most of the human sera. Changes outside this sequence affected the reactivities differentially. Six overlapping dodeca-peptides, shifted in the sequence by single residues, lacked antigenicity in a competition assay, suggesting antigenic dependence on an ordered peptide conformation, which the longer peptides may preferentially assume. 19- and 21-mers with overlapping sequences competed to different extents with each other for binding to the antibodies of 3 human sera, illustrating that more than one antigenic structure in this narrow region can be recognized by a single polyclonal serum.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Klasse</LastName>
<ForeName>P J</ForeName>
<Initials>PJ</Initials>
<AffiliationInfo>
<Affiliation>Department of Medical Microbiology, University of Lund, Sweden.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Pipkorn</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Blomberg</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Mol Immunol</MedlineTA>
<NlmUniqueID>7905289</NlmUniqueID>
<ISSNLinking>0161-5890</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000939">Epitopes</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015700">HIV Envelope Protein gp41</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>2ZD004190S</RegistryNumber>
<NameOfSubstance UI="D013912">Threonine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CitationSubset>X</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001666" MajorTopicYN="N">Binding Sites, Antibody</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015700" MajorTopicYN="N">HIV Envelope Protein gp41</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015497" MajorTopicYN="N">HIV-1</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007124" MajorTopicYN="N">Immunoenzyme Techniques</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008968" MajorTopicYN="N">Molecular Conformation</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D013912" MajorTopicYN="N">Threonine</DescriptorName>
<QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>1991</Year>
<Month>6</Month>
<Day>1</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>1991</Year>
<Month>6</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>1</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>1991</Year>
<Month>6</Month>
<Day>1</Day>
<Hour>0</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">1713646</ArticleId>
<ArticleId IdType="doi">10.1016/0161-5890(91)90130-c</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002995 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002995 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:1713646
   |texte=   A cluster of continuous antigenic structures in the transmembrane protein of HIV-1: individual patterns of reactivity in human sera.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:1713646" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021